Analyst Expectations for Mind Medicine's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Mind Medicine (NASDAQ:MNMD) received 5 bullish analyst ratings with an average 12-month price target of $23.4, a significant increase from the previous average price target of $5.00. No bearish or indifferent ratings were observed.
October 23, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mind Medicine has received 5 bullish analyst ratings in the last quarter with an average 12-month price target of $23.4, a significant increase from the previous average price target of $5.00.
The increase in the average price target and the bullish ratings from analysts indicate a positive outlook for Mind Medicine. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100